Sinopharm
1099.HK
#2838
Rank
โ‚น600.81 B
Marketcap
โ‚น192.53
Share price
-3.49%
Change (1 day)
-13.82%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2025: โ‚น7.870 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.870 Trillion. In 2025 the company made a revenue of โ‚น7.870 Trillion an increase over the revenue in the year 2024 that were of โ‚น7.667 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2025

Annual revenue

Year Revenue Change
2025โ‚น7.870 T2.65%
2024โ‚น7.667 T-5.1%
2023โ‚น8.079 T5.42%
2022โ‚น7.664 T-2.1%
2021โ‚น7.828 T16.85%
2020โ‚น6.699 T14.95%
2019โ‚น5.828 T21.52%
2018โ‚น4.796 T5.93%
2017โ‚น4.527 T27.22%
2016โ‚น3.558 T5.37%
2015โ‚น3.377 T9.14%
2014โ‚น3.094 T17.22%
2013โ‚น2.639 T25.94%
2012โ‚น2.095 T34.61%
2011โ‚น1.557 T55.34%
2010โ‚น1.002 T35.79%
2009โ‚น738.18 B37.56%
2008โ‚น536.64 B31.43%
2007โ‚น408.32 B40.26%
2006โ‚น291.11 B